MedTrace Logo

Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas

NCT01539668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5079

Last updated 2014-02-26

No results posted yet for this study

Summary

This study evaluates the women cervical samples through molecular tests in order to:

1\. Deploy the test careHPV (hybrid capture test) in mobile unities of the Barretos Cancer Hospital to evaluate their performance;

Conditions

  • Cervical Cancer Squamous Cell
  • Human Papilloma Virus Infection
  • Human Papilloma Virus-Related Carcinoma
  • Prevention

Sponsors & Collaborators

  • QIAGEN Gaithersburg, Inc

    collaborator INDUSTRY

  • Barretos Cancer Hospital

    lead OTHER

Principal Investigators

  • Adriana T Lorenzi, MSc

  • Adhemar Longatto-Filho, PhD · Barretos Cancer Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-12-31
Completion
2014-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01539668 on ClinicalTrials.gov